mesoprogestins (Schering AG)

N/A

Report date: 2025/11/17 14:45:25
NME

Base Information

Drug Namemesoprogestins (Schering AG)
Drug Alias Namemifepristone analogs (Jenapharm)mesoprogestins (Jenapharm)antiprogestogens (Jenapharm)J-824J-1042
ClassificationSmall molecules > Steroids
Mechanisms of ActionProgesterone modulators
TargetsProgesterone
Therapy Area/IndicationsOestrogen deficiency symptomsContraceptionEndometriosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJenapharm Gmbh & Co Kg
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJenapharm Gmbh & Co Kg
Active IndicationsN/A
Inactive IndicationsOestrogen deficiency symptomsContraceptionEndometriosis

Other Information

ATC CodeN/A
Related LinksN/A